Please login to the form below

Not currently logged in
Email:
Password:

Biogen

This page shows the latest Biogen news and features for those working in and with pharma, biotech and healthcare.

Sanofi gets US okay for $270,000 blood disorder drug Cablivi

Sanofi gets US okay for $270,000 blood disorder drug Cablivi

It is the first US drug approval for Sanofi’s rare blood disorders franchise, which also includes haemophilia drugs acquired along with Biogen spin-off Bioverativ in 2018.

Latest news

More from news
Approximately 98 fully matching, plus 255 partially matching documents found.

Latest Intelligence

  • Drug launches to watch in 2019 Drug launches to watch in 2019

    only other SMA treatment available, Biogen’s Spinraza.

  • Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available? Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?

    However, research from RAND and the University of Southern California that was sponsored by Biogen has found that several European countries lack the capacity to rapidly move a disease-modifying treatment

  • Deal Watch October 2018

    Samsung Bioepis is a joint venture between Samsung and Biogen Idec; the latter recently (June 2018) invested $700m to bring its stake in the jv to 49.9%.

  • No incentive for a cure No incentive for a cure

    to 12-week course. And Spinraza from Biogen, the first ever disease-modifying treatment for spinal muscular atrophy (SMA), which increases the body’s ability to produce SMN protein critical to.

  • Deal Watch January 2018

    Biogen's spin-out, Bioverativ, had not even got past its first anniversary as a Nasdaq-listed company before being snapped up by Sanofi for $11.6bn (although this is not ... Option, licence. 223. Karyopharm Therapeutics/ Biogen. Oral SINE compound

More from intelligence
Approximately 1 fully matching, plus 35 partially matching documents found.

Latest appointments

More from appointments
Approximately 16 fully matching, plus 32 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 14 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Complete HealthVizion

Complete HealthVizion is a global team of fresh thinkers who aspire to be better every day. We create life-changing medical...

Latest intelligence

International Childhood Cancer Day 2019
The number of new cases per year is shocking but the journey and the outlooks have vastly improved. We've pulled together an infographic to show just what we mean with...
Immuno-oncology in 2019: the rapid evolution continues
Immunotherapy is pharma’s biggest growth driver – how will it develop in 2019?...
Mixing up Focus Groups
A nice spread of homogeneous participants in a focus groups are often a go to for reliable research outcomes but there's much to be said for mixing it up and...

Infographics